Publication Name	World Journal of Hepatology
Manuscript ID	78259
Country	China

Received	2022-07-03 13:59
Peer-Review Started	2022-07-03 14:01
To Make the First Decision
Return for Revision	2022-09-30 13:25
Revised	2022-10-21 13:17
Second Decision	2022-12-20 08:07
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-12-21 01:04
Articles in Press	2022-12-21 01:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-12-21 07:43
Publish the Manuscript Online	2022-12-23 10:01

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Systematic Reviews
Article Title	Liver chemistries in severe or non-severe cases of COVID-19: A systematic review and meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Xuan Dong, Dan-Yi Zeng, Qing-Qing Xing, Mei-Zhu Hong and Jin-Shui Pan
Funding Agency and Grant Number
Corresponding Author	Jin-Shui Pan, MD, PhD, Chief Doctor, Professor, Department of Hepatology, First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road , Fuzhou 350005, Fujian Province, China. j.s.pan76@gmail.com
Key Words	Systematic reviews and Meta-Analyses; COVID-19; SARS-CoV-2; Meta-analysis; Liver chemistries; Severe
Core Tip	Data on abnormal liver chemistries related to coronavirus disease (COVID-19) are cumulating but are potentially confusing. We performed a meta-analysis of 57 studies that included a total of 11,052 patients with COVID-19. We noted that patients with abnormal liver test results are at higher risk of progression to severe disease and close monitoring of liver chemistries provides early warning against disease progression.
Publish Date	2022-12-23 10:01
Citation	Dong X, Zeng DY, Xing QQ, Hong MZ, Pan JS. Liver chemistries in patients with severe or non-severe COVID-19: A systematic review and meta-analysis. World J Hepatol 2022; 14(12): 2012-2024
URL	https://www.wjgnet.com/1948-5182/full/v14/i12/2012.htm
DOI	https://dx.doi.org/10.4254/wjh.v14.i12.2012

Full Article (PDF)	WJH-14-2012.pdf
Full Article (Word)	WJH-14-2012.docx
Manuscript File	78259_Auto_Edited-LJH-JLW.docx
Answering Reviewers	78259-Answering reviewers.pdf
Audio Core Tip	78259-Audio core tip.m4a
Biostatistics Review Certificate	78259-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	78259-Conflict-of-interest statement.pdf
Copyright License Agreement	78259-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	78259-Language certificate.pdf
Supplementary Material	78259-Supplementary material.pdf
Peer-review Report	78259-Peer-review(s).pdf
Scientific Misconduct Check	78259-Bing-Liu JH-2.jpg
Scientific Misconduct Check	78259-CrossCheck.jpg
Scientific Editor Work List	78259-Scientific editor work list.pdf
CrossCheck Report	78259-CrossCheck report.pdf